Real-World Estimates of Adrenal Insufficiency-Related Adverse Events in Children With Congenital Adrenal Hyperplasia

Salma R Ali1,2, Jillian Bryce2, Houra Haghpanahan3

  • 1Developmental Endocrinology Research Group, School of Medicine, Dentistry & Nursing, University of Glasgow, Glasgow, UK.

Insights

Congenital adrenal hyperplasia (CAH) patients experience sick day episodes (SDE), but their link to adrenal crises (AC) needs clarification. Infectious illness is a common trigger for both SDE and AC in children with CAH.

Area of Science:

  • Endocrinology
  • Pediatric Health
  • Rare Diseases

Background:

  • Congenital adrenal hyperplasia (CAH) is linked to adrenal crises (AC).
  • The association between CAH and patient/clinician-reported sick day episodes (SDE) is less understood.
  • Understanding SDE is crucial for managing CAH, particularly in children.

Purpose of the Study:

  • To investigate the clinical factors associated with SDE and AC in children with classic 21-hydroxylase deficiency CAH.
  • To analyze data from the International CAH Registry to compare SDE and AC occurrences.
  • To examine differences in SDE and AC between low/middle-income countries (LMIC) and high-income countries (HIC).

Main Methods:

  • Retrospective analysis of data from 518 children with classic 21-hydroxylase deficiency CAH.
  • Data collected from 34 centers across 18 countries via the International CAH Registry.
  • Evaluation of 5388 visits over 2300 patient-years, focusing on SDE and AC events.

Main Results:

  • Infectious illness was the most frequent precipitant for both SDE (72%) and AC (47%).
  • The median SDE per patient-year was significantly higher in LMIC (0.75) compared to HIC (0.11) (P < 0.001).
  • No significant difference in AC rates was observed between LMIC and HIC.

Conclusions:

  • Real-world data from the I-CAH Registry reveal variability in adverse events related to adrenal insufficiency.
  • Further research is needed to standardize the definition of SDE in CAH care.
  • Improved definition and understanding of SDE can enhance clinical benchmarks for CAH management.
Abstract

Related Concept Videos

Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
2.7K
Hormones of the Adrenal Glands01:31

Hormones of the Adrenal Glands

Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and...
4.2K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
664
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
134
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
524
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.5K